Beam Therapeutics CEO Sells $739K of Stock Beam CEO Evans sold $739,000 of stock on Apr 6, 2026, per SEC Form 4 and Investing.com; institutional investors should normalize the sale to holdings and market cap.

Beam Therapeutics CEO Sells $739K of Stock: Beam CEO Evans sold $739,000 of stock on Apr 6, 2026, per SEC Form 4 and Investing.com; institutional investors should normalize the sale to holdings and market cap. 👈 Read full analysis #BeamTherapeutics #StockMarket #Investing #CEOCorner #FinancialNews